Skip to main content

Flora Growth Regains NASDAQ Compliance, Secures Continued Listing

Tipranks - Thu Aug 21, 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest update is out from Flora Growth ( (FLGC) ).

Flora Growth Corp. has successfully regained compliance with NASDAQ’s minimum bid price requirement, ensuring its continued listing on the exchange. This development marks a significant milestone for the company, as it had previously been notified of non-compliance earlier in the year. By maintaining a closing bid price above $1.00 for 10 consecutive trading days, Flora Growth has secured its position on NASDAQ, which is crucial for its market visibility and investor confidence.

The most recent analyst rating on (FLGC) stock is a Hold with a $18.00 price target. To see the full list of analyst forecasts on Flora Growth stock, see the FLGC Stock Forecast page.

Spark’s Take on FLGC Stock

According to Spark, TipRanks’ AI Analyst, FLGC is a Neutral.

Flora Growth’s overall stock score is heavily impacted by its weak financial performance, characterized by declining revenue, persistent losses, and increased leverage. Technical analysis further supports a bearish outlook with negative momentum indicators. Valuation concerns, including a negative P/E ratio and lack of dividend yield, further weigh down the score. The absence of earnings call data and corporate events leaves these areas unaddressed.

To see Spark’s full report on FLGC stock, click here.

More about Flora Growth

Flora Growth Corp. operates in the cannabis industry, focusing on the cultivation and distribution of cannabis products. The company is listed on the NASDAQ and the Frankfurt Stock Exchange, indicating its international market presence.

Average Trading Volume: 7,606

Technical Sentiment Signal: Sell

Current Market Cap: $13.52M

For a thorough assessment of FLGC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.